NEPHROS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
NEPHROS, INC. (NEPH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.03% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-03-12
- NEPHROS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.03%, a 66.67% decline from fiscal 2024.
- NEPHROS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was 0.09%.
- NEPHROS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2018 was -0.11%.
- NEPHROS, INC. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2017 was -12.46%, a 1384.54% decline from fiscal 2016.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.03% 10-K · filed 2026-03-12 | |
| 2024-12-31 | 0.09% 10-K · filed 2026-03-12 | |
| 2018-12-31 | -0.11% 10-K · filed 2019-03-12 | |
| 2017-12-31 | -12.46% 10-K · filed 2019-03-12 | |
| 2016-12-31 | 0.97% 10-K · filed 2018-02-26 | |
| 2015-12-31 | -3.11% 10-K · filed 2017-03-20 | |
| 2014-12-31 | -3.10% 10-K · filed 2016-03-30 | |
| 2013-12-31 | 6.50% 10-K · filed 2015-04-15 | -3.00% 10-K · filed 2014-03-28 |
| 2012-12-31 | -2.29% 10-K · filed 2014-03-28 | |
| 2011-12-31 | -3.07% 10-K · filed 2013-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |